BioMarin Pharmaceutical Inc. received Food and Drug Administration approval of its gene therapy Roctavian to treat hemophilia A, the agency said late...
BioMarin Pharmaceutical Inc. BMRN received Food and Drug Administration approval of its gene therapy Roctavian to treat hemophilia A, the agency said late Thursday. The FDA said Roctavian was the first gene therapy to treat adults with severe hemophilia A, a serious genetic disorder that affects the gene that makes the protein that casues blood to clot, increasing the risk of uncontrolled bleeding. Shares of BioMarin were up 1% after hours, following a 3.
... BioMarin Pharmaceutical Inc. BMRN received Food and Drug Administration approval of its gene therapy Roctavian to treat hemophilia A, the agency said late Thursday. The FDA said Roctavian was the first gene therapy to treat adults with severe hemophilia A, a serious genetic disorder that affects the gene that makes the protein that casues blood to clot, increasing the risk of uncontrolled bleeding. Shares of BioMarin were up 1% after hours, following a 3.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
US FDA approves BioMarin's gene therapy for hemophilia AThe U.S. Food and Drug Administration on Thursday approved BioMarin Pharmaceutical's gene therapy for severe hemophilia A, the company said, giving patients with the inherited bleeding disorder an alternative to regular injections of missing blood proteins.
Leer más »
Credit Suisse downgrades Pfizer, says pharma giant will struggle to keep up with competitorsAnalyst Trung Huynh downgraded the pharmaceutical stock to neutral from outperform.
Leer más »
ACT UP’s Radical Activism Saved Lives During the AIDS EpidemicThe movement stood up to the president, pharmaceutical companies, and the CDC.
Leer más »
US FDA declines to approve Regeneron's higher-dose Eylea, shares tumbleU.S. health regulators said on Tuesday they declined to approve a higher-dose version of Regeneron Pharmaceuticals' drug Eylea for treatment of a disease that is the leading cause of blindness among the elderly, and the company's shares fell on the setback to its effort to defend the blockbuster treatment against a fast-gaining rival.
Leer más »
Dozens of frozen fruit products sold at 6 major retailers recalled by FDAIn the recall notice, SunOpta and the FDA urged consumers to check their freezers for the recalled product and to not consume it, but rather discard the product or return it to the store for a full refund.
Leer más »
Myasthenia Gravis Drug Gets FDA NodThe monoclonal antibody rozanolixizumab (Rystiggo) is indicated to treat adults with the two most common subtypes of generalized myasthenia gravis.
Leer más »